Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pulmonary Disease, Chronic Obstructive × Salmeterol Xinafoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pulmonary Disease, Chronic Obstructive 1 Lymphoma, Follicular 1

Interventions

Standard of Care 2 vilanterol 1 tocilizumab 1 Tiotropium Bromide 1 Surgical Procedures, Operative 1 Salmeterol Xinafoate 1 Rehabilitation 1 Practice Guidelines as Topic 1 Immunoglobulin G 1 Fluticasone-Salmeterol Drug Combination 1 Fluticasone 1 Educational Status 1 Disulfides 1 Albuterol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03745261 2018-11-19

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Henan University of Traditional Chinese Medicine

Phase 3 Unknown

Lymphoma, Follicular, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡